Effect of Liraglutide in Obese Subjects With Moderate or Severe Obstructive Sleep Apnoea. A 32 Week Randomised, Double-blind, Placebo-controlled, Parallel Group, Multi-centre and Multinational Trial

This trial is conducted in North America. The aim of the trial is to investigate the effect of liraglutide in obese subjects with sleep apnoea.

本试验于北美地区开展，旨在探究利拉鲁肽（liraglutide）对合并睡眠呼吸暂停的肥胖受试者的治疗效果。